Researchers Evaluate Cost-Effectiveness of Non-invasive Prenatal Screening in Quebec
Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org For Immediate Release Wednesday, October 19, 2016 10:15 a.m. U.S. Pacific Time Findings Reported at ASHG 2016 Annual Meeting BETHESDA, MD – Adding non-invasive prenatal genetic screening (NIPS) for fetal chromosomal abnormalities to the current prenatal testing strategy in Quebec would be more cost-effective than current... Read More